Akela Pharma, Inc. Delists From The Toronto Stock Exchange
VANCOUVER, Dec. 7, 2012 /CNW Telbec/ - Akela Pharma, Inc. (TSX: AKL) (the "Corporation") has announced that voluntary delisting of the Coproration's securities from the Toronto Stock Exchange (TSX) will occur at the close of trading on December 7, 2012.
The decision to voluntarily delist has been made by the Corporation due Akela Pharma, Inc.'s inability to maintain the continuous listing requirements of the TSX. The securities of the Corporation will not be actively listed on a market. The Corporation has not made the required filings of the Corporation's interim financial statements, management's discussion and analysis and CEO and CFO certifications for the period ended September 30, 2012 and has been placed on the list of delinquent filers. The Corporation's securities were placed on a cease trade order on November 23, 2012 by the Investment Industry Regulatory Organization of Canada (IIROC). The Toronto Stock Exchange initiated a delisting review of the Corporation's securities on August 27, 2012.
While the Company has sought alternatives, no assurances can be given that any transaction may occur. Further no assurances can be given that any transaction would result in any value for any of the various stakeholders of the Corporation. As previously disclosed in the notes to the Corporation's interim financial statements as of June 30, 2012, doubt remains regarding the Corporation's ability to continue as a going concern and there is no assurance that the actions taken to date will result in sufficient funds being generated to enable the Company to continue as a going concern.
About Akela Pharma, Inc.Akela Pharma, Inc.'s common shares trade on The Toronto Stock Exchange ("TSX") under the symbol "AKL" with approximately 32.4 million shares outstanding.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV